Walter M. Gregory

University of Sheffield — United Kingdom

Medicine · Health Sciences

63h-index15.8kcitations414works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(200), Protein Degradation and Inhibitors(98), Cancer Treatment and Pharmacology(63), Peptidase Inhibition and Analysis(46), Bone health and treatments(44)

Publications413 total

Frequency-specific microcurrent improves hand function and Raynaud’s symptoms in scleroderma: results of two pilot studies
Lara D. Veeken·2025Open Access
Figure 2 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Supplementary Data 1 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Figure 5 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Data from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Figure 4 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Figure 6 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Figure 3 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Figure 1 from Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
2025Open Access
Modeling MRD Changes in Myeloma to Understand Treatment Effects, Predict Outcomes, and Investigate Curative Potential
Clinical Cancer Research·2025Open Access
Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use
Scientific Reports·2025Open Access
Optimising research investment by simulating and evaluating monitoring strategies to inform a trial: a simulation of liver fibrosis monitoring
BMC Medical Research Methodology·2024Open Access
Final Analysis of the Randomised UK MRA Myeloma XI+ Trial Examining Krdc (carfilzomib, lenalidomide, dexamethasone and cyclophosphamide) As Induction Therapy for Newly Diagnosed Multiple Myeloma Patients
Blood·2024Open Access
MRD and Molecular Risk Status Help to Define Optimal Maintenance Delivery Strategies after ASCT: Long Term Outcomes of the UK MRA Myeloma XI Trial Comparing Lenalidomide to Observation
Blood·2024· 2 cited
Optimising the Duration of Therapy for Newly Diagnosed Transplant Ineligible Patients - Analysis of Long Term Follow up Data from the UK MRA Myeloma XI Trial
Blood·2024· 1 citedOpen Access
P55 Predicting liver related morbidity and mortality in non-cirrhotic chronic liver disease: early results from the ELUCIDATE trial
2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT
Health Technology Assessment·2024Open Access
BoHFAB. The impact of adjuvant zoledronate therapy on bone health in postmenopausal patients with early breast cancer
Journal of bone oncology·2024Open Access
Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study
Journal of Bone and Mineral Research·2024· 7 citedOpen Access
Supplementary table 1 from Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment
2023Open Access
page 1 of 21Next →

Frequent Co-authors

Gareth J. Morgan(26), Faith E. Davies(24), Graham Jackson(20), Mark T. Drayson(17), Gordon Cook(17), Roger G. Owen(16), Brian A. Walker(11), Sue Bell(10), J. Anthony Child(10), David A. Cairns(10), Martin Kaiser(9), Charlotte Pawlyn(9), Fiona M. Ross(9), John R Jones(7), Christopher P. Wardell(6), Alexander J. Szubert(6), Matthew Jenner(6), Sylvia Feyler(5), Dil Begum(5), David C. Johnson(5)